US EditionEU Secures Relief: 15% Tariff Ceiling on US Pharmaceuticals
The EU’s deal limits U.S. tariffs on its pharmaceutical exports to 15%, preventing the 100% tariffs announced by President Trump, securing trade stability for the sector.
- On Friday, the European Union and Japan said they secured a 15% tariff ceiling on U.S. pharmaceuticals, semiconductors and lumber under the end-July trade deal.
- On Thursday, Trump posted on Truth Social that a 100% tariff applies to branded or patented drugs unless firms build a U.S. manufacturing plant.
- There will be no tariff if construction has started, and Swiss company Roche recently broke ground on a U.S. unit while Swiss rival Novartis made a large U.S. pledge earlier this year.
- The European Commission said the United States intends to promptly keep pharmaceutical tariffs below 15%, while Dublin remains cautious and Ireland's deputy prime minister Simon Harris said they will study the impact.
- Negotiations meanwhile continue as the US reduced EU cars duties from 27.5% to 15%, while 50% tariffs on EU steel and aluminium remain.
27 Articles
27 Articles
Sefcovic: For those goods the rate may not exceed 15%, Washington is so far complying with all agreed commitments.
Commissioner Sefcovic points out that all agreed commitments have been met so far, while a Commission spokesman claims: "The Union is the only U.S. trading partner to have achieved this result"
Pharma tariffs: The EU's confident it can dodge US measures
US President Donald Trump announced on Thursday 100% tariffs on pharmaceutical products imported into the US, but the European Commission remains hopeful that the deal concluded with Washington this summer—setting 15% tariffs on EU goods—will also apply to the sector.
The European Commission trusts that the announcement by US President Donald Trump that he will impose 100% tariffs on drug imports will not affect him. And he does so on the basis of the joint communiqué issued by Brussels and Washington on 21 August last on the trade agreement to which both parties reached at the end of July: “The United States intends to ensure without delay that the tariff rate [...] on pharmaceuticals, semiconductors and tim…
The European Commission ruled this Friday that it will affect European productions the 100% tariff that US President Donald Trump said will impose on all imports from the pharmaceutical sector.This because the trade agreement that Brussels and Washington closed this summer establishes a 15% ceiling as a maximum charge for any import purchase to the US market from the EU.
Coverage Details
Bias Distribution
- 45% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
